Aspartame and Artificial Additives Artificial sweeteners, such as aspartame, can negatively impact glutathione levels and contribute to oxidative stress
A closer look at how weight loss drug semaglutide improves the cardiovascular health of obese patients without diabetes Weekly treatments of semaglutide can reduce the risk of cardiovascular death, heart attack or stroke among obese patients without diabetes, according to new data presented at the American Heart Associations Scientific Sessions 2023 conference and simultaneously published in The New England Journal of Medicine .[1] Subcutaneous treatments of semaglutide, a GLP-1 receptor agonist originally developed to treat diabetes, are being sold and marketed by Novo Nordisk under the brand name Wegovy
Standard pieces of liver tissues from mice were embedded in an optimal cutting temperature gel and stained with Oil Red O solution 25
Additionally, these medications can have positive effects on conditions like sleep apnea and can contribute to overall health improvement in individuals with obesity
HPLC used to separate, identify, and quantify each component in a mixture has been significantly upgraded, leading to greater separation efficiency, adaptability and speed
